1[1]Stephen K,Tyring,Istvan A,et al.a radomized,controlled molecular study of condylomata acuminate clearance during treatment with imiquimod[ J].J Infect Dis 1998;178:551.
2[2]Stanley MA.Mechanism of action of imiquimod[ J ].Papillomavirus Report,1999;10(2):23.
3[3]Miller RL,Gerster JF,Owens ML,et al.Imiquimod applied topically:a novel immune response modifier and new class of drug[J].Intern J Immunopharm,1999;21:1.
5[5]Edwards L,Imiquimod in clinical practice[J].J Am Acad Dermatol,2000 ;43:S12.
6[6]Vilata J J,Sierra X.Efficacy of imiquimod 5% cream in treating genital and perianal warts.
7[7]Beutner KR,Tyring SK,Trfaffer Jr JKF,et al.Imiguimod,a patient-applied immune-respose modifier for treatment of external genital warts[J].Antimicrob Agents Chenother,1998;42:789.
8[8]Beutner KR,Spruance SL Hongharm AJ,et al.Treatment of genital warts with an immane -response modifer (Imiquimod)[J].JAmAcadDermatol,1998;38(PtI):230.
9[9]Garland SM,Sellors JW,Wikstrom A,et al.Imiquimod 5%cream is a safe and effective self-applied treatment for anogenictal warts-results of an open-label,multicentre phate Ⅲ B Trial[J].InterJSTD&AIDS,2001 ;12:722.
10[10]Gollnick H,Barasso R,Jappe U,et al.Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day[J].Intern J of STD&AIDS,2001 ;12:22.
3Syed TA, Ahmadpour OA, Ahmad SA, et al. Management of toenail onychomycosis with 2% butenafine and 20% urea cretan: a placebo-controlled, double-blind study. J Dermatol, 1998 , 25: 648-652.
4Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs, 1999 , 58: 375-390.
5Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol, 1998, 134: 25-30.
6Beutner KR, Spruance SL, Hougham AJ, et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol, 1998, 38(2 Pt 1 ): 230-239.
